Oracle: Real AI Growth, a Negative Cash Bill — and a Stock Cut in Half

On the surface, Oracle's latest quarter was everything an AI-stock owner could want. Revenue rose 30% year over year to $19.3 billion in the fiscal first quarter, cloud revenue jumped 62%, the backlog of contracted future business swelled to $664 billion, and management raised its full-year outlook above what analysts had expected. Shares jumped roughly 7% in extended trading.

Then the market opened and gave it all back, sliding the stock below its prior close. That reversal is worth pausing on, because the market's worry is not what most people assume. The growth — almost uniquely among AI stories — is no longer just a pitch. The problem is how Oracle is paying for it, and that bill shows up in the cash-flow statement, not the earnings report.

The growth finally has receipts

Begin with what the crowd selling the dip is ignoring. Oracle's growth is no longer narrative; it is booked. The core AI business, cloud infrastructure, more than doubled, growing 121% to $7.4 billion. The company delivered 850 megawatts of new data-center capacity in a single quarter and says customer demand for AI cloud training and inference is growing faster than supply.

The most telling number is the order backlog — what Oracle calls remaining performance obligations, or RPO. It stood at $664 billion, up more than 300% from a year earlier and above the roughly $630 billion consensus. That figure — a remaining-performance-obligation measure that includes contracted but not yet recognized revenue, deferred revenue, and uncollected invoices — is Oracle's version of an order book for the next several years. Management even raised guidance: at least $90 billion of revenue and $8.10 of non-GAAP earnings per share for fiscal 2027, both nudging past the figures analysts already had.

On revenue and growth, this is an acceleration quarter, not a deceleration. If the stock's problem were the business, the stock would not be where it is.

Two bills: one easy, one not

The problem is the second bill. Building AI data centers at this speed is not profitable in the current quarter — it requires enormous up-front spending. Oracle spent $28.5 billion on capital expenditures in the first quarter, more than three times the $8.5 billion it committed a year earlier. Free cash flow, the cash left after those investments, was negative $5.4 billion for the quarter, versus negative $362 million a year ago. On a trailing-twelve-month basis, free cash flow is roughly negative $29 billion against about $88 billion of net debt.

This is the heart of why Oracle keeps selling off even when it beats. A company whose growth is real but whose cash generation is deeply negative is borrowing and issuing stock to fund its own boom. Oracle sold about $20 billion of new common stock in the quarter to help pay for the build-out, diluting shareholders even as it grows.

None of this is new fear. The stock lost nearly a fifth of its value in a single week back in June, its worst week since 2001, on identical concerns: capital spending surging 162% for the year, negative free cash flow, and a heavy debt load. The market has been circling this same cash-flow question for months, not days.

What the halving has already priced

That repetition is the useful part for an investor deciding whether the slide is an opportunity or a warning. The stock has been cut roughly in half over the past year, trading around $150 against a 52-week high near $330. Oracle trades at about 15 times trailing enterprise value to EBITDA and, on its own raised guidance of $8.10 in non-GAAP EPS, in the high teens on forward earnings — a discount to faster-is-slower software peers despite Oracle growing faster. On an EV/EBITDA basis it is cheaper than Salesforce, which grows at a fraction of the rate.

In other words, the share price has already done a great deal of the de-risking. The market is not paying a rich multiple for the AI boom; it is paying 15 times a cash-burning growth story and calling it appropriately discounted. When a multiple compresses this far while the business accelerates, the setup is a two-sided bet: the pessimistic valuation is a genuine cushion, but it only pays off if the cash actually arrives.

That cash arrival is the single metric that decides the next phase. The encouraging leading indicator is that operating cash flow hit a record $23 billion in the quarter, up 184%, before the enormous investments were subtracted. Oracle's build-out could still convert into positive free cash flow if capital spending peaks while that operating cash keeps climbing — the backlog gives it contracted demand to recognize over coming years. If instead the build-out keeps accelerating faster than operating cash can catch up, the negative cash flow, and the debt layered on top of it, remains the thing that caps the multiple no matter how good the growth looks.

For an investor today, the honest read is not yet a headline buy or sell. A stock that has halved on genuine operating acceleration has improved risk/reward, but the improvement is only real if the next few quarters show the cash turning. Watch whether Oracle's capital spending eventually peaks and whether free cash flow moves toward break-even, because that — not the 30% revenue growth — is what would prove this was a reset the market overdid. Until then, the market's caution is not irrational; it is just early.